Consulting
Since 1997, executives at leading organizations—including 11 of the 15 largest biopharmaceutical manufacturers—have called on Dr. Adam J. Fein for his experience, analyses, and insights about pharmaceutical economics and the drug distribution system.
Dr. Fein collaborates with his clients to help them make better strategic decisions and achieve their business goals, customizing his work for clearly established outcomes. Clients also benefit from his on-call advice and research support.
All work is performed with utmost confidentiality and discretion. Here are examples of our recent projects with clients:
Since 1997, executives at leading organizations—including 11 of the 15 largest biopharmaceutical manufacturers—have called on Dr. Adam J. Fein for his experience, analyses, and insights about pharmaceutical economics and the drug distribution system.
Dr. Fein collaborates with his clients to help them make better strategic decisions and achieve their business goals, customizing his work for clearly established outcomes. Clients also benefit from his on-call advice and research support.
All work is performed with utmost confidentiality and discretion. Here are examples of our recent projects with clients:
- Helping a pharmaceutical manufacturer develop and negotiate a more favorable fee-for-service agreement with its pharmaceutical wholesalers
- Showing a health care products manufacturer how to lower the risks associated with its contracting and go-to-market strategy
- Evaluating a pharmaceutical manufacturer's potential authorized generics partners
- Developing non-traditional channel strategy options for launching an innovative medical product
- Teaching a pharmaceutical manufacturer's national account managers to interact more strategically with key customers
- Improving a pharmaceutical manufacturer's contracting and negotiating strategy with Pharmacy Benefit Managers (PBMs)
Clients
Dr. Fein's clients are primarily senior executives at manufacturers of pharmaceuticals, biopharmaceuticals, or medical devices. Here are some of the primary functional areas supported at clients:
- Managed markets
- Trade account management
- Commercial operations
- Managed care contracting
- Payor marketing
- Reimbursement strategy
- Channel development
Institutional investors and private equity firms can speak with Dr. Fein on pharmaceutical industry issues via his exclusive affiliation with Gerson Lehrman Group (GLG). GLG clients can request a consultation via his GLG web page.
Please note that Dr. Fein's work with healthcare products manufacturers and buyers precludes him from any business consulting assignments with wholesalers or distributors of healthcare products and pharmaceuticals.
Copyright © 2010, Pembroke Consulting. All rights reserved.